Prolonged sterilisation of development rights supports capital-gains treatment, while business-income disallowances cannot govern capital-gains comput...
Additional evidence in transfer pricing dispute leads to fresh examination, while tax deductions, TDS credit, fee and refund interest require verifica...
Category II AIF pass-through taxation preserves non-business income character; investment receipts cannot be reclassified without applying recognised ...
Mutual fund maturity rules require proper rollover, redemption, disclosure, and due diligence; investor gains cannot excuse regulatory breaches or pen...
Threshold exemption excludes exempt services, while stamp-paper purchases avoid reverse charge; consequential service tax penalties were also set asid...
Food supplements cannot be classified as proprietary Ayurvedic...
Food supplement classification requires common parlance and authoritative tests, preventing treatment as proprietary Ayurvedic medicines without supporting evidence.
Contents
Summary
Note
Bookmark
Share
✓ Copied successfully !
Print
Print Options
For full text, please login
Login to TaxTMI
Verification Pending
The Email Id has not been verified. Click on the link we have sent on
Food supplements cannot be classified as proprietary Ayurvedic medicines solely by common parlance or a manufacturer's drug licence. Classification requires both common parlance and authoritative tests, including evidence that the products are intended for diagnosis, treatment or cure. Products purchased under CST registration and sold unchanged as food supplements, without the dealer holding a drug-sale licence, remain taxable under the residuary entry. Chapter IV-A of the Drugs and Cosmetics Act continues to regulate Ayurvedic, Siddha and Unani drugs; exclusion from Chapter IV does not remove sale-licensing requirements. The Tribunal may award costs in tax appeals, as compensatory costs for vexatious litigation are an inherent power not barred by the Act.
Food supplements cannot be classified as proprietary Ayurvedic medicines solely by common parlance or a manufacturer's drug licence. Classification requires both common parlance and authoritative tests, including evidence that the products are intended for diagnosis, treatment or cure. Products purchased under CST registration and sold unchanged as food supplements, without the dealer holding a drug-sale licence, remain taxable under the residuary entry. Chapter IV-A of the Drugs and Cosmetics Act continues to regulate Ayurvedic, Siddha and Unani drugs; exclusion from Chapter IV does not remove sale-licensing requirements. The Tribunal may award costs in tax appeals, as compensatory costs for vexatious litigation are an inherent power not barred by the Act.
Note: It is a system-generated summary and is for quick reference only.
TaxTMI 
of 4784
Join Channel
TaxTMI 
